临床路径在终末期肾脏病患者中的应用

目的探讨临床路径在终末期肾病患者中的应用效果。方法将60例终末期肾脏病患者随机分为路径组30例和非路径组30例,路径组采用制定好的临床路径实施诊疗、护理工作,非路径组采用传统方法进行诊疗,比较2组病人平均住院时间、平均住院费用,平均药品费、平均检验费、对医疗护理工作的满意度。结果路径组病人平均住院天数、平均住院费用、平均药品费、平均检验费明显低于非路径组(P<0.01),对医疗护理满意度明显优于非路径组(P<0.01)。结论在终末期肾病患者中实施临床路径可减少住院天数,降低住院费用,有利于病人主动参与诊疗和护理,促进了病人术后生活自理能力的恢复,提高病人的满意度。

Clinical Path in end-stage renal disease patients

Objective Application of clinical pathway in patients with end-stage renal disease application effect. Methods 60 patients with end-stage renal disease patients were randomly divided into the path of group of 30 cases and30 cases of non path group, Path group by making good clinical pathway implementation, nursing diagnosis . Non path group using traditional methods of diagnosis and treatment .Comparing two groups of patients, the average hospitalization time. The average hospitalization expenses, The average drug charges.Average inspection fee.On the medical and nursing work satisfaction. Results Path patient group the average length of stay .The average cost of hospitalization .The average drug charges.Average inspection fee was significantly lower than the non path group (P < 0.01). On medical care satisfaction . was better than the non path group (P < 0.01). Conclusion In end-stage renal disease patients in the implementation of clinical pathway can reduce the length of hospital stay. Decrease the cost of hospitalization. Helps patients to actively participate in treatment and nursing. Promoting patient postoperative self-care ability recovery. Improving patient satisfaction.